Division of Neonatology Clinical Studies

1 - 1 of 1

BPD STAR Pilot Trial

This study will test whether supplemental oxygen therapy, a common post-discharge treatment for BPD, improves outcomes. Enrolled infants, between the ages of 34-44 weeks Post Menstrual Age, with moderate or severe BPD, will be randomly assigned to higher or lower oxygen saturation target ranges. The study intervention will begin in the hospital and will continue at home until 6 months Corrected Age. IRB 17-014522